AnaBios Corporation today announced the acquisition of Cell Systems, a human primary cell and cell culture media company located in Kirkland, Washington.
3D models are often applauded for being more predictive than 2D cultures, but not all scientists know how to maximize their 3D models’ biological relevance to reach their full potential. Using primary human cells (derived directly from human tissues) can greatly enhance the biological relevance of your models and steer your experiments in the right direction from the start. In a study by Kim et al., researchers use primary liver sinusoidal endothelial cells (Cat# ACBRI 566) to construct a 3D microfluidic human liver-chip to better understand how breast cancer-derived extracellular vehicles (EVs) can influence metastasis in the liver.
Using primary human cells in your in vitro models can greatly enhance the biological relevance of your research, resulting in real human insights and saving time and money down the road. Cell Systems Primary Human Glomerular Endothelial Cells (Cat#. ACBRI 128) were used in a human in vitro model by the University Health Center of Quebec to better understand chronic antibody-mediated rejection (ABMR) in kidney transplant recipients. Across multiple experiments in the study, the results gathered from the primary glomerular cell model show similar patterns to what was observed in kidney transplant recipients.
Your cell culture coating solution can greatly affect not only cell health and proliferation, but also your lab and protocol schedule and research program velocity. Cell Systems’ Attachment Factor is your optimized solution to promoting cell attachment for all types of tissue culture surfaces. Unlike other coating solutions (such as collagen) that require you to prepare and coat your tissue culture wares well in advance, Attachment Factor’s coating will be ready for cell plating after just 5 seconds. Attachment Factor gives you the flexibility to start coating your tissue culture wares when you are truly ready to plate cells. No...